Majid Marjani to Kaplan-Meier Estimate
This is a "connection" page, showing publications Majid Marjani has written about Kaplan-Meier Estimate.
Connection Strength
0.026
-
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869.
Score: 0.026
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.